Volume 30, Number 5—May 2024
Synopsis
Coccidioidomycosis-Related Hospital Visits, Texas, USA, 2016–2021
Figure 2
References
- Williams SL, Chiller T. Update on the epidemiology, diagnosis, and treatment of coccidioidomycosis. J Fungi (Basel). 2022;8:666. DOIPubMedGoogle Scholar
- McCotter OZ, Benedict K, Engelthaler DM, Komatsu K, Lucas KD, Mohle-Boetani JC, et al. Update on the Epidemiology of coccidioidomycosis in the United States. Med Mycol. 2019;57(Supplement_1):S30–40. DOIPubMedGoogle Scholar
- Gorris ME, Ardon-Dryer K, Campuzano A, Castañón-Olivares LR, Gill TE, Greene A, et al. Advocating for coccidioidomycosis to be a reportable disease nationwide in the United States and encouraging disease surveillance across North and South America. J Fungi (Basel). 2023;9:83. DOIPubMedGoogle Scholar
- Centers for Disease Control and Prevention. Valley fever (coccidioidomycosis) statistics. July 18, 2022 [cited 2023 Jun 7]. https://www.cdc.gov/fungal/diseases/coccidioidomycosis/statistics.html
- Centers for Disease Control and Prevention. Valley fever maps. February 22, 2021 [cited 2023 Jun 7]. https://www.cdc.gov/fungal/diseases/coccidioidomycosis/maps.html
- Gorris ME, Treseder KK, Zender CS, Randerson JT. Expansion of coccidioidomycosis endemic regions in the United States in response to climate change. Geohealth. 2019;3:308–27. DOIPubMedGoogle Scholar
- Peterson C, Chu V, Lovelace J, Almekdash MH, Lacy M. Coccidioidomycosis cases at a regional referral center, West Texas, USA, 2013–2019. Emerg Infect Dis. 2022;28:848–51. DOIPubMedGoogle Scholar
- Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health. Valley fever (coccidioidomycosis). November 7, 2022 [cited 2023 Jun 7]. https://www.cdc.gov/niosh/topics/valleyfever/risk.html
- Texas Hospital Inpatient Discharge Public Use Data File, 2016–2021. Texas Department of State Health Services, Center for Health Statistics, Austin, Texas.
- Texas Outpatient Public Use Data File, 2016–2021. Texas Department of State Health Services, Center for Health Statistics, Austin, Texas.
- Kazakova SV, Baggs J, Parra G, Yusuf H, Romano SD, Ko JY, et al. Declines in the utilization of hospital-based care during COVID-19 pandemic. J Hosp Med. 2022;17:984–9. DOIPubMedGoogle Scholar
- Pu J, Donovan FM, Ellingson K, Leroy G, Stone J, Bedrick E, et al. Clinician practice patterns that result in the diagnosis of coccidioidomycosis before or during hospitalization. Clin Infect Dis. 2021;73:e1587–93. DOIPubMedGoogle Scholar
- Gudo ES, Pinto G, Weyer J, le Roux C, Mandlaze A, José AF, et al. Serological evidence of rift valley fever virus among acute febrile patients in Southern Mozambique during and after the 2013 heavy rainfall and flooding: implication for the management of febrile illness. Virol J. 2016;13:96. DOIPubMedGoogle Scholar
- California Department of Public Health. Valley fever in California dashboard [cited 2024 Feb 22]. https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/ValleyFeverDashboard.aspx
- Arizona Department of Health Services. Valley fever [cited 2024 Feb 22]. https://www.azdhs.gov/preparedness/epidemiology-disease-control/valley-fever/index.php
- Texas Demographic Center. Texas population projections program, 2018 [cited 2024 Feb 22]. https://demographics.texas.gov/Projections/2018/#pageContent
- Centers for Disease Control and Prevention. Community-acquired pneumonia (CAP): clinical testing algorithm for coccidioidomycosis. November 27, 2023 [cited 2024 Mar 4]. https://www.cdc.gov/fungal/diseases/coccidioidomycosis/diagnosticalgorithms/index.html
Page created: March 22, 2024
Page updated: April 23, 2024
Page reviewed: April 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.